V Karthikarajam, Pushpaketu Nalubolu, Badhai Samit, Mishra Amaresh, Sahu Subrat, Debata Ipsita, Debata P K
Department of General Surgery, Kalinga Institute of Medical Sciences, Bhubaneswar, IND.
Department of Community Medicine, Kalinga Institute of Medical Sciences, Bhubaneswar, IND.
Cureus. 2024 Nov 20;16(11):e74126. doi: 10.7759/cureus.74126. eCollection 2024 Nov.
Treating gangrenous cholecystitis (GC) can be a challenge. It necessitates urgent intervention due to its elevated mortality risk. Prompt identification of risk factors and intervention are essential for halting inflammatory cascade and preventing further complications. This study aimed to evaluate the factors for early prediction of gangrenous changes in patients with acute cholecystitis.
A prospective study was carried out among 340 diagnosed adult acute cholecystitis patients, admitted under the Department of General Surgery of a tertiary medical college between May 2022 and April 2024. Data were compiled into Excel and analyzed using the SPSS (Statistical Product and Service Solutions) software (IBM SPSS Statistics for Windows, Version 21.0. IBM Corp., Armonk, NY). Data were analyzed using descriptive statics, chi-square test, and unpaired t-test. A p-value less than 0.05 was considered statistically significant.
Out of 340 acute cholecystitis patients, 27 (7.9%) progressed to GC. It was more prevalent among males (22/27, 81.5%), among patients in the 51-70 years age group (15/27, 55.5%), and among patients with comorbidities (diabetes mellitus and coronary artery disease) (23/27, 85.2%) with a significant association (p < 0.001, p = 0.010, and p < 0.001, respectively). The presence of fever (p = 0.002) and vomiting (p = 0.040) was significantly associated with gangrenous outcomes in the patients. The mean values of lab parameters like White Blood Cells (WBCs), serum bilirubin (SBIL), serum glutamic-oxaloacetic transaminase (SGOT), serum glutamic pyruvic transaminase (SGPT), and alkaline phosphatase (ALP) were significantly higher among patients with GC. Ultrasound imaging parameters showed a significantly higher asymmetrical gallbladder (GB) wall (27, 100%), intraluminal membrane (23/27, 85.2%), pericholecystic collection (23/27, 85.2%), and acalculous GB (9/27, 33.3%) among GC patients. In the case of Contrast-Enhanced Computed Tomography (CECT) for GC, the test demonstrated relatively high sensitivity (74.1%) and specificity (85.6%). All patients with GC underwent emergency cholecystectomy.
The study highlighted various demographic, clinical, and imaging factors linked to a high risk of developing GC, including older age, male gender, elevated laboratory markers (such as WBC count, SBIL, SGOT, SGPT, and ALP), and imaging features like GB calculi, increased GB wall thickness, wall symmetry, intraluminal membrane, and pericholecystic collection. Employing a comprehensive approach that incorporates demographic, clinical, and imaging data is essential for predicting and guiding treatment decisions effectively.
治疗坏疽性胆囊炎(GC)可能是一项挑战。由于其死亡风险升高,需要紧急干预。及时识别风险因素并进行干预对于阻止炎症级联反应和预防进一步并发症至关重要。本研究旨在评估急性胆囊炎患者坏疽性改变的早期预测因素。
对2022年5月至2024年4月期间在一所三级医学院普通外科收治的340例确诊为成人急性胆囊炎的患者进行了一项前瞻性研究。数据被录入Excel,并使用SPSS(统计产品与服务解决方案)软件(IBM SPSS Statistics for Windows,版本21.0。IBM公司,纽约州阿蒙克)进行分析。使用描述性统计、卡方检验和非配对t检验进行数据分析。p值小于0.05被认为具有统计学意义。
在340例急性胆囊炎患者中,27例(7.9%)进展为GC。在男性(22/27,81.5%)、51 - 70岁年龄组患者(15/27,55.5%)以及患有合并症(糖尿病和冠状动脉疾病)的患者(23/27,85.2%)中更为常见,且具有显著相关性(分别为p < 0.001、p = 0.010和p < 0.001)。发热(p = 0.002)和呕吐(p = 0.040)的存在与患者的坏疽性结局显著相关。坏疽性胆囊炎患者的白细胞(WBC)、血清胆红素(SBIL)、血清谷草转氨酶(SGOT)、血清谷丙转氨酶(SGPT)和碱性磷酸酶(ALP)等实验室参数的平均值显著更高。超声成像参数显示,坏疽性胆囊炎患者的胆囊壁不对称(27例,100%)、腔内隔膜(23/27,85.2%)、胆囊周围积液(23/27,85.2%)和无结石胆囊(9/27,33.3%)显著更多。在坏疽性胆囊炎的对比增强计算机断层扫描(CECT)检查中,该检查显示出相对较高的敏感性(74.1%)和特异性(85.6%)。所有坏疽性胆囊炎患者均接受了急诊胆囊切除术。
该研究强调了与发生坏疽性胆囊炎高风险相关的各种人口统计学、临床和影像学因素,包括年龄较大、男性、实验室指标升高(如白细胞计数、血清胆红素、血清谷草转氨酶、血清谷丙转氨酶和碱性磷酸酶)以及影像学特征,如胆囊结石、胆囊壁增厚、壁对称性、腔内隔膜和胆囊周围积液。采用综合方法纳入人口统计学、临床和影像学数据对于有效预测和指导治疗决策至关重要。